Colrain Capital LLC Pfizer Inc Transaction History

Colrain Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $155,130 - $182,003	-4,886 Reduced 23.85%	15,600 $573,000
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $527,100 - $639,450	-17,500 Reduced 46.07%	20,486 $670,000
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $364,905 - $521,369	-13,500 Reduced 26.22%	37,986 $1.24 Million
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $128,388 - $145,704	-3,900 Reduced 7.04%	51,486 $2.02 Million
Q3 2019 Oct 23, 2019	SELL	$32.49 - $42.13 $253,422 - $328,614	-7,800 Reduced 12.34%	55,386 $1.99 Million
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $617,566 - $693,384	-16,700 Reduced 20.9%	63,186 $2.74 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $29,587 - $32,506	-789 Reduced 0.98%	79,886 $3.39 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $489,752 - $522,125	-14,850 Reduced 15.55%	80,675 $2.93 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $614,969 - $713,449	-19,272 Reduced 16.79%	95,525 $3.39 Million
Q4 2017 Feb 07, 2018	SELL	$33.26 - $35.29 $2.37 Million - $2.52 Million	-71,301 Reduced 38.31%	114,797 $4.16 Million
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $5.77 Million - $6.36 Million	186,098	186,098 $6.64 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Colrain Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Colrain Capital LLC with notifications on news.